|
Study #: 2024 Published: 02/2006 Pages: 240 Full Study Price: US$ 4,800 Per Page Price: US$ 30.00 Pharmaceuticals in China to 2010 - Market Research, Market Share, Market Size, Sales, Demand Forecast, Market Leaders, Company Profiles, Industry Trends Pharmaceutical demand in China will grow 13.6% annually through 2010. Western proprietary ethical drugs will grow the fastest while Western generic ethical medicines will remain the top segment. Drug stores will capture some revenues away from the dominant hospital market. This study analyzes ¥198 billion Chinese pharmaceutical industry. It presents historical demand data (1995, 2000, 2005) and forecasts to 2010 and 2015 for Western and traditional Chinese pharmaceuticals by therapeutic class (e.g., anti-infective, gastrointestinal, cardiovascular, hormones, biologicals and vaccines, nutritional, central nervous system, respiratory), and by market. The study also considers market environment indicators, evaluates company market share and profiles 42 major industry players including Shanghai Pharmaceutical, Yangtze River Pharmaceutical, Guangzhou Pharmaceutical, Harbin Pharmaceutical Group, Pfizer Pharmaceuticals, Nanjing Medical, and GSK China Investment.
TABLE OF CONTENTS
SECTION PAGE
INTRODUCTION xi
I. EXECUTIVE SUMMARY 1
II. MARKET ENVIRONMENT 4
General 4
Economic Factors 5
Demographic Patterns 7
Regulated Birth Planning 8
Mortality Trends 9
Migration 10
Medical Conditions 10
Acute Conditions 11
Chronic Conditions 14
Health Insurance Coverage 16
Basic Medical Insurance 17
Cooperative Health Insurance 18
Other Public Health Insurance 19
Private Health Insurance 19
National Health Expenditures 20
Medical Providers 23
Hospitals 24
Clinics 27
Physicians 28
Patient Activity 30
Hospital Care 32
Surgical Procedures 34
Outpatient Visits 34
III. PHARMACEUTICAL OVERVIEW 37
General 37
Shipments 39
Regulatory Considerations 41
Product Classification Systems 41
New Product Approval Processes 42
Manufacturing Standards 43
Intellectual Property Rights 44
Channels of Distribution 44
Price Controls 45
Import Requirements 46
Chinese Trade in Pharmaceuticals 47
Western Pharmaceuticals 48
Shipments 49
Ethical Drugs 50
Generic Drugs 52
Proprietary Drugs 54
Shipments 54
Over-the-Counter (OTC) Drugs 56
Demand Patterns 57
Shipments 59
Traditional Chinese Medicines 60
Demand Patterns 61
Shipments 62
Types of Medicines 63
Astragalus 64
Atractylodes 66
Bupleurum 67
China Root 67
Cinnamon 68
Coptis 68
Ephedra 69
Ginger 70
Ginseng 70
Hoelen 71
Licorice 71
Peony 72
Rehmannia 72
Rhubarb 72
Salvia 73
Tang-kuei 74
Other Selected Traditional Chinese Medicines 74
Herbal Combinations 76
IV. THERAPEUTIC CLASSES 78
General 78
Shipments 80
Anti-Infective Agents 81
Demand 82
Cephalosporins 83
Penicillins 84
Other Antibiotics 86
Antiviral Agents 87
Antifungal Agents 89
Other Anti-Infective Agents 90
Shipments 92
Gastrointestinal Agents 93
Demand 94
Antacids & Acid Reducers 95
Proton Pump Inhibitors 97
Laxatives 97
Antidiarrheal Agents 98
Other Gastrointestinal Agents 99
Shipments 100
Cardiovascular Agents 101
Demand 102
Cardiac Drugs 103
Antilipemic Agents 104
Antihypertensive Agents 105
Other Cardiovascular Agents 106
Shipments 107
Hormones & Related Agents 109
Demand 109
Antineoplastic Agents 110
Antidiabetic Agents 112
Oral Antidiabetic Agents 113
Corticosteroids 115
Estrogens & Combinations 115
Other Hormones 116
Shipments 117
Biologicals & Vaccines 119
Demand 120
Vaccines 120
Blood & Blood Derivatives 121
Shipments 122
Nutritional Agents 123
Demand 124
Vitamins 125
Nutrients & Tonics 126
Parenteral Nutritionals 126
Other Nutritional Agents 127
Shipments 127
Central Nervous System Agents 128
Demand 128
Pain Control Agents 130
Psychotherapeutic Agents 130
Other Central Nervous System Agents 131
Shipments 131
Respiratory Agents 133
Demand 133
Cough/Cold Preparations 134
Antihistamines 135
Bronchodilators 136
Other Respiratory Agents 137
Shipments 137
Other Therapeutic Groups 139
Dermatological Agents 140
Genito-Urinary Agents 141
All Other Therapies 142
Shipments 143
V. MARKETS 145
General 145
Hospitals 147
Consumer Market 149
Physicians 150
Clinics & Other Markets 151
VI. INDUSTRY STRUCTURE 153
General 153
Market Share 154
Competitive Strategies 157
Shanghai Pharmaceutical Company Limited 159
Yangtze River Pharmaceutical Group Company Limited 159
Guangzhou Pharmaceutical Company Limited 160
Harbin Pharmaceutical Group Company Limited 160
Pfizer Pharmaceuticals 160
Nanjing Medical Company Limited 161
GSK China Investment (GlaxoSmithKline) 161
Xian-Janssen Pharmaceutical (Johnson & Johnson) 162
Beijing Double-Crane Pharmaceutical Company Limited 163
Chongqing Taiji Industry Group Company Limited 163
Investment 163
Mergers & Acquisitions 164
Licensing & Related Agreements 166
Marketing & Distribution 171
Manufacturing 171
Company Profiles 172
AstraZeneca plc 173
Bayer AG 175
Beijing Double-Crane Pharmaceutical Company Limited 177
Beijing Tongrentang Company Limited 179
Bristol-Myers Squibb Company 181
China National Medicines Corporation Limited 183
Chongqing Taiji Industry Group Company Limited 184
Chongqing Tong Jun Ge Company Limited 185
GlaxoSmithKline plc 186
Guangzhou Pharmaceutical Company Limited 189
Hangzhou MSD Pharmaceutical Company,
see Merck & Company Incorporated
Harbin Pharmaceutical Group Company Limited 190
Henan Topfond Pharmaceutical Company Limited 191
Huadong Medicine Company Limited 193
Jiangsu Hengrui Medicine Company Limited 194
Jinling Pharmaceutical Company Limited 195
Jiuzhitang Company Limited 196
Johnson & Johnson 197
Lilly (Eli) and Company 200
Livzon Pharmaceutical Group Incorporated 202
Mead Johnson Nutritionals Guangzhou Branch,
see Bristol-Myers Squibb Company
Merck & Company Incorporated 204
Nanjing Medical Company Limited 206
North China Pharmaceutical Group Corporation 208
Novartis AG 209
Ouyi Pharma Company, see Shijiazhuang Pharmaceutical
Group Company
Pfizer Incorporated 213
Roche Holding Limited 216
Sanjiu Medical & Pharmaceutical Company Limited 218
Schering-Plough Corporation 219
Shandong Dong-E E-Jiao Company Limited 221
Shandong E-hua Biotechnics Pharmaceutical Company,
see Shandong Dong-E E-Jiao Company Limited
Shandong Lukang Pharmaceutical Company Limited 222
Shandong Xinhua Pharmaceutical Company Limited 223
Shandong Zibo Xinhua-Chermferm Pharmaceutical
Industrial Company, see Shandong Xinhua
Pharmaceutical Company
Shanghai Fosun Pharmaceutical Group Company 225
Shanghai Pharmaceutical Company Limited 226
Shanghai Roche Pharmaceutical, see Roche Holding
Shanghai Schering-Plough Pharmaceutical Company, see
Schering-Plough Corporation
Shanghai Worldbest Pharmaceuticals Company Limited 227
Shijiazhuang Pharmaceutical Group Company Limited 228
Sino-American Shanghai Squibb Pharmaceuticals, see
Bristol-Myers Squibb Company
Tianjin Tasly Pharmaceutical Company Limited 231
Tianjin Tianyao Pharmaceutical Company Limited 232
Tianjin Zhongxin Pharmaceutical Group Corporation
Limited 233
Wyeth 234
Xian-Janssen Pharmaceutical, see Johnson & Johnson
Yangtze River Pharmaceutical Group Company Limited 236
Yunnan Baiyao Group Company Limited 237
Zhejiang Hisun Pharmaceutical Company Limited 238
Zhejiang Medicine Company Limited 239
LIST OF TABLES
TABLE NUMBER PAGE
SECTION I -- EXECUTIVE SUMMARY
Summary Table 3
SECTION II -- MARKET ENVIRONMENT
1 Macroeconomic Indicators 5
2 Resident Population by Age Group 8
3 Acute Conditions by Type 11
4 Selected Chronic Conditions by Type 15
5 Health Insurance Coverage 17
6 National Health Expenditures by Type & Source 23
7 Medical Providers 24
8 Patient Activity 32
SECTION III -- PHARMACEUTICAL OVERVIEW
1 Pharmaceutical Demand by Type 38
2 Pharmaceutical Shipments by Type 40
3 China Trade in Pharmaceuticals 48
4 Western Pharmaceutical Demand by Type 49
5 Western Pharmaceutical Shipments by Type 50
6 Western Ethical Drug Demand by Therapeutic Group 52
7 Western Ethical Drug Shipments by Therapeutic Group 56
8 Western Over-the-Counter (OTC) Drug Demand
by Therapeutic Group 57
9 Western Over-the-Counter (OTC) Drug Shipments
by Therapeutic Group 60
10 Traditional Chinese Medicine (TCM) Demand by Therapeutic
Group 62
11 Traditional Chinese Medicine (TCM) Shipments
by Therapeutic Group 63
SECTION IV -- THERAPEUTIC CLASSES
1 Pharmaceutical Demand by Therapeutic Group 79
2 Pharmaceutical Shipments by Therapeutic Group 80
3 Anti-Infective Agent Demand 83
4 Anti-Infective Agent Shipments 93
5 Gastrointestinal Agent Demand 95
6 Gastrointestinal Agent Shipments 101
7 Cardiovascular Agent Demand 102
8 Cardiovascular Agent Shipments 108
9 Hormone & Related Agent Demand 110
10 Hormone & Related Agent Shipments 119
11 Biological & Vaccine Demand 120
12 Biological & Vaccine Shipments 123
13 Nutritional Agent Demand 125
14 Nutritional Agent Shipments 128
15 Central Nervous System Agent Demand 129
16 Central Nervous System Agent Shipments 132
17 Respiratory Agent Demand 134
18 Respiratory Agent Shipments 138
19 Other Pharmaceutical Demand 140
20 Other Pharmaceutical Shipments 144
SECTION V -- MARKETS
1 Pharmaceutical Demand by Market 146
2 Hospitals -- Pharmaceutical Demand 149
3 Consumer Market -- Pharmaceutical Demand 150
4 Physicians Market -- Pharmaceutical Demand 151
5 Clinics & Other Markets -- Pharmaceutical Demand 152
SECTION VI -- INDUSTRY STRUCTURE
1 China Pharmaceutical Sales by Company, 2004 156
2 Selected Acquisitions & Divestitures 166
3 Selected Cooperative Agreements 168
LIST OF CHARTS
CHART NUMBER PAGE
SECTION III -- PHARMACEUTICAL OVERVIEW
1 Pharmaceutical Demand by Type, 2005 39
2 Pharmaceutical Shipments by Type, 2005 41
SECTION IV -- THERAPEUTIC CLASSES
1 Pharmaceutical Demand by Therapeutic Class, 2005 79
2 Pharmaceutical Shipments by Therapeutic Class, 2005 81
SECTION V -- MARKETS
1 Pharmaceutical Demand by Market, 2005 147
SECTION VI -- INDUSTRY STRUCTURE
1 China Pharmaceutical Market Share by Company, 2005 157
You may view the complete table of contents without charge and select individual records for purchase ($30.00 each) or purchase the complete study.
Home About Freedonia Contact Freedonia Search Studies Browse Catalog The Freedonia Group - The First Choice In Industry Research8 © Copyright 2010 The Freedonia Group, Inc.
|